Status:
COMPLETED
Study Evaluating Safety and Adherence to Treatment With Etanercept in Adults With Psoriatic Arthritis
Lead Sponsor:
Pfizer
Conditions:
Arthritis, Psoriatic
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to evaluate if the data obtained in controlled clinical trials are confirmed when Enbrel is used in usual clinical practice in Belgium according to local reimbursement criteri...
Eligibility Criteria
Inclusion
- Active erosive psoriatic arthritis of poly-articular type or active erosive or with joint space narrowing psoriatic arthritis of oligo-articular type
- At least 18 years old
- Have fulfilled reimbursement criteria for Enbrel in psoriatic arthritis of poly-articular type or oligo-articular type
- Physician decides to prescribe Enbrel or patient is already on Enbrel
- Give written informed consent at time of inclusion to study
Exclusion
- NA
Key Trial Info
Start Date :
October 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2012
Estimated Enrollment :
303 Patients enrolled
Trial Details
Trial ID
NCT00938015
Start Date
October 1 2004
End Date
April 1 2012
Last Update
May 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Leuven, Belgium, 3000